Treatment of equine degenerative joint disease with autologous peripheral blood-derived mesenchymal stem cells: a case report

被引:7
作者
Spaas, J. H. [1 ]
Oosterlinck, M. [2 ]
Broeckx, S. [3 ]
Dumoulin, M. [2 ]
Saunders, J. [4 ]
Van Soom, A. [3 ]
Pille, F. [2 ]
Van de Walle, G. R. [1 ]
机构
[1] Univ Ghent, Fac Vet Med, Dept Comparat Physiol & Biometr, B-9820 Merelbeke, Belgium
[2] Univ Ghent, Fac Vet Med, Dept Surg & Anesthesiol Domest Anim, B-9820 Merelbeke, Belgium
[3] Univ Ghent, Fac Vet Med, Dept Reprod Obstet & Herd Hlth, B-9820 Merelbeke, Belgium
[4] Univ Ghent, Fac Vet Med, Dept Vet Med Imaging & Small Anim Orthoped, B-9820 Merelbeke, Belgium
来源
VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT | 2012年 / 81卷 / 01期
关键词
BONE-MARROW; STROMAL CELLS; THERAPY; TENDON; HORSE; IMPLANTATION;
D O I
10.21825/vdt.v81i1.18372
中图分类号
S85 [动物医学(兽医学)];
学科分类号
090604 [动物药学];
摘要
A 5-year-old German Warmblood stallion with chronic lameness, attributable to degenerative joint disease (DJD) of the pastern joint unresponsive to medical treatments, was treated with autologous mesenchymal stem cells (MSC). These MSC were isolated from the peripheral blood (PB) of the patient and injected into the pastern joint, at a concentration of 2.5x10(6) cells, twice with an 8-week interval. The positive response to this stem cell treatment was documented by visual gait evaluation as well as objective pressure plate analyses. This paper is the first to describe the use of autologous PB-derived MSC to treat a horse suffering from chronic DJD. The favorable outcome of this single case may stimulate further research on the use of equine peripheral blood as a source of autologous MSC in equine regenerative medicine.
引用
收藏
页码:11 / 15
页数:5
相关论文
共 23 条
[1]
Chondrogenic potential of mesenchymal stromal cells derived from equine bone marrow and umbilical cord blood [J].
Berg, L. C. ;
Koch, T. G. ;
Heerkens, T. ;
Besonov, K. ;
Thomsen, P. D. ;
Betts, D. H. .
VETERINARY AND COMPARATIVE ORTHOPAEDICS AND TRAUMATOLOGY, 2009, 22 (05) :363-370
[2]
Cell therapy for tendon repair in horses: An experimental study [J].
Crovace, A. ;
Lacitignola, L. ;
De Siena, R. ;
Rossi, G. ;
Francioso, E. .
VETERINARY RESEARCH COMMUNICATIONS, 2007, 31 (Suppl 1) :281-283
[3]
Optimization of the Isolation, Culture, and Characterization of Equine Umbilical Cord Blood Mesenchymal Stromal Cells [J].
De Schauwer, Catharina ;
Meyer, Evelyne ;
Cornillie, Pieter ;
De Vliegher, Sarne ;
van de Walle, Gerlinde R. ;
Hoogewijs, Maarten ;
Declercq, Heidi ;
Govaere, Jan ;
Demeyere, Kristel ;
Cornelissen, Maria ;
Van Soom, Ann .
TISSUE ENGINEERING PART C-METHODS, 2011, 17 (11) :1061-1070
[4]
The end of the beginning for pluripotent stem cells [J].
Donovan, PJ ;
Gearhart, J .
NATURE, 2001, 414 (6859) :92-97
[5]
Evaluation of Adipose-Derived Stromal Vascular Fraction or Bone Marrow-Derived Mesenchymal Stem Cells for Treatment of Osteoarthritis [J].
Frisbie, David D. ;
Kisiday, John D. ;
Kawcak, Chris E. ;
Werpy, Natasha M. ;
Mcllwraith, C. Wayne .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2009, 27 (12) :1675-1680
[6]
Future directions in treatment of joint disease in horses [J].
Frisbie, DD .
VETERINARY CLINICS OF NORTH AMERICA-EQUINE PRACTICE, 2005, 21 (03) :713-+
[7]
Medical treatment of osteoarthritis in the horse - A review [J].
Goodrich, LR ;
Nixon, AJ .
VETERINARY JOURNAL, 2006, 171 (01) :51-69
[8]
Equine embryonic stem-like cells and mesenchymal stromal cells have different survival rates and migration patterns following their injection into damaged superficial digital flexor tendon [J].
Guest, D. J. ;
Smith, M. R. W. ;
Allen, W. R. .
EQUINE VETERINARY JOURNAL, 2010, 42 (07) :636-642
[9]
AN ASSESSMENT OF WASTAGE IN THOROUGHBRED RACING FROM CONCEPTION TO 4 YEARS OF AGE [J].
JEFFCOTT, LB ;
ROSSDALE, PD ;
FREESTONE, J ;
FRANK, CJ ;
TOWERSCLARK, PF .
EQUINE VETERINARY JOURNAL, 1982, 14 (03) :185-198
[10]
Stem cell therapy for joint problems using the horse as a clinically relevant animal model [J].
Koch, Thomas G. ;
Betts, Dean H. .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (11) :1621-1626